HIV patients get continued access to key drug in safety study
Disease control
Completed
This study gave HIV-1 patients continued access to the drug etravirine until they could switch to a local treatment. It included 180 people aged 2 and older who had already benefited from the drug in a previous trial. The main goal was to monitor safety while providing the medica…
Phase: PHASE3 • Sponsor: Janssen Sciences Ireland UC • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC